CA125 and Ovarian Cancer: A Comprehensive Review

Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker CA125 has been used as the primary ovarian cancer marker for the past four decades. The focus on diagnosing ovarian cancer in stages I and II using CA125 as a diagnostic biomarker has not improved patients'...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2020-12, Vol.12 (12), p.3730
Hauptverfasser:	Charkhchi, Parsa, Cybulski, Cezary, Gronwald, Jacek, Wong, Fabian Oliver, Narod, Steven A, Akbari, Mohammad R
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Asymptomatic Biomarkers Cancer therapies Carcinogenesis Carcinoma Chemotherapy Diagnosis Disease Hormone replacement therapy Malignancy Medical prognosis Medical screening Mutation Ovarian cancer Review Surgery Tumors Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!